Next Article in Journal
Current Staging Procedures in Urinary Bladder Cancer
Previous Article in Journal / Special Issue
Overview of Five-Years of Experience Performing Non-Invasive Fetal Sex Assessment in Maternal Blood
Article Menu

Export Article

Open AccessReview
Diagnostics 2013, 3(2), 291-314;

Non-Invasive Screening Tools for Down’s Syndrome: A Review

School of Biomedical and Biological Sciences, Plymouth University Peninsula School of Medicine and Dentistry, Plymouth University, Plymouth, PL4 8AA, UK
Department of Obstetrics, St Michael's Hospital, Southwell Street, Bristol, BS2 8EG, UK
Author to whom correspondence should be addressed.
Received: 10 April 2013 / Revised: 14 May 2013 / Accepted: 16 May 2013 / Published: 31 May 2013
(This article belongs to the Special Issue Advance in Prenatal Diagnosis)
Full-Text   |   PDF [628 KB, uploaded 31 May 2013]   |  


Down’s syndrome (DS) is the most common genetic cause of developmental delay with an incidence of 1 in 800 live births, and is the predominant reason why women choose to undergo invasive prenatal diagnosis. However, as invasive tests are associated with around a 1% risk of miscarriage new non-invasive tests have been long sought after. Recently, the most promising approach for non-invasive prenatal diagnosis (NIPD) has been provided by the introduction of next generation sequencing (NGS) technologies. The clinical application of NIPD for DS detection is not yet applicable, as large scale validation studies in low-risk pregnancies need to be completed. Currently, prenatal screening is still the first line test for the detection of fetal aneuploidy. Screening cannot diagnose DS, but developing a more advanced screening program can help to improve detection rates, and therefore reduce the number of women offered invasive tests. This article describes how the prenatal screening program has developed since the introduction of maternal age as the original “screening” test, and subsequently discusses recent advances in detecting new screening markers with reference to both proteomic and bioinformatic techniques. View Full-Text
Keywords: screening; Down’s syndrome; non-invasive; biomarkers; sonographic markers; next-generation-sequencing screening; Down’s syndrome; non-invasive; biomarkers; sonographic markers; next-generation-sequencing

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Sillence, K.A.; Madgett, T.E.; Roberts, L.A.; Overton, T.G.; Avent, N.D. Non-Invasive Screening Tools for Down’s Syndrome: A Review. Diagnostics 2013, 3, 291-314.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Diagnostics EISSN 2075-4418 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top